✦ LIBER ✦

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma

✍ Scribed by Hamza, Mohamed A.; Mandel, Jacob J.; Conrad, Charles A.; Gilbert, Mark R.; Yung, W. K. Alfred; Puduvalli, Vinay K.; DeGroot, John F.

Book ID: 125366709
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 264 KB
Volume: 119
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-014-1460-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes in Patients with Recurrent/Prog

Outcomes in Patients with Recurrent/Progressive Glioblastoma Treated with Bevacizumab Funded by a Regional Cancer Drug Fund

✍ Dixit, S.; Hatfield, P.; Clenton, S.; Loughrey, C.; Hingorani, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 308 KB

Long-term outcome of early versus delaye

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

✍ Robert A. Hauser; Mark F. Lew; Howard I. Hurtig; William G. Ondo; Joanne Wojcies 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB 👁 1 views

## Abstract The purpose of this study to compare the long‐term clinical outcome of early versus delayed rasagiline treatment in early Parkinson's disease (PD). Subjects (N = 404) were randomly assigned to initial treatment with rasagiline (early‐start group) or placebo for 6 months followed by rasa

A meta-analysis of bevacizumab alone and

A meta-analysis of bevacizumab alone and in combination with irinotecan in the treatment of patients with recurrent glioblastoma multiforme

✍ Zhang, Guobin; Huang, Shengyue; Wang, Zhongcheng 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Single-agent bevacizumab or lomustine ve

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial

✍ Taal, Walter; Oosterkamp, Hendrika M; Walenkamp, Annemiek M E; Dubbink, Hendriku 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 358 KB

Preferences for treatment outcomes in pa

Preferences for treatment outcomes in patients with heart failure: Symptoms versus survival

✍ Stanek, Eric J.; Oates, Melanie B.; McGhan, William F.; Denofrio, David; Loh, Ev 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Limited impact of prognostic factors in

Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen

✍ E. Tabouret, M. Barrie, A. Thiebaut, M. Matta, C. Boucard… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 216 KB